Showing 1471-1480 of 2150 results for "".
- Endogena Therapeutics Secures FDA Green Light to Initiate Trials for Geographic Atrophy Treatmenthttps://modernod.com/news/endogena-therapeutics-secures-fda-green-light-for-breakthrough-amd-treatment/2481909/Endogena Therapeutics announced that the FDA has granted clearance for Endogena's investigational new drug (IND) application, allowing the company to commence a first-in-human study in 2024 for its geographic atrophy drug cadidate EA 2351. This milestone marks the com
- Heidelberg Engineering Receives FDA Clearance for Anterion Platformhttps://modernod.com/news/heidelberg-engineering-announces-fda-clearance-of-anterion-platform/2481889/Heidelberg Engineering has received FDA clearance of its Anterion platform, designed to improve anterior segment diagnostics and streamline practice workflow. “Building upon our previous CE-marking, we are thrilled that the Anterion platform is
- ESCRS Releases the 2022-2023 EUREQUO Annual Reporthttps://modernod.com/news/escrs-releases-the-2022-2023-eurequo-annual-report/2481801/The European Society of Cataract & Refractive Surgeons (ESCRS) has released the 2022-2023 EUREQUO annual report. ESCRS is marking the 15th anniversary of the establishment of the EUREQUO Registry with the announcement that the cataract and refractive database has grown to more than 4 mil
- Amber Ophthalmics Announces First Patient Enrolled in Phase 2/3 Trial Evaluating Nexagon for the Treatment of PCEDhttps://modernod.com/news/amber-ophthalmics-announces-first-patient-enrolled-in-phase-23-trial-evaluating-nexagon-for-the-treatment-of-pced/2481785/Amber Ophthalmics announced that Mark S. Gorovoy, MD, has enrolled the first patient in the AMB-01-006 (NEXPEDE-1), a randomized, double-masked, vehicle-controlled phase 2/3 clinical trial designed to evaluate two concentrations of Nexagon (lufepirsen ophthalmic gel) for
- Norlase Secures $11M in New Funding Following Regulatory Clearance of ECHO Pattern Laserhttps://modernod.com/news/norlase-secures-11m-in-new-funding-following-regulatory-clearance-of-echo-pattern-laser/2481634/Norlase announced it has secured $11 million in funding, its largest investment round thus far. Norlase said the funding will enable it to accelerate the production ramp-up of the ECHO pattern laser, which just received FDA clearance and CE Mark earlier this month, as well as
- BVI Completes Enrollment of Finevision HP IDE Clinical Studyhttps://modernod.com/news/bvi-completes-enrollment-of-finevision-hp-ide-clinical-study/2481581/BVI announced it has completed enrollment of its US Investigational Device Exemption (IDE) clinical study for its latest hydrophobic trifocal IOL, Finevision HP. The milestone marks the final implantation of the 539th patient enrolled in the prospective, multicenter, rand
- Keranova Announces Clinical Study Results for Robotic Laser Technologyhttps://modernod.com/news/keranova-announces-clinical-study-results-for-robotic-laser-technology/2481345/Keranova announced the finalization of the regulatory clinical studies of FemtoMatrix, its robotic laser technology. With the positive results, the company said it will now apply for CE marking for this new class of surgical equipment in cataract surgery. According to Ker
- CooperVision MiSight 1 Day Officially Launches in Chinahttps://modernod.com/news/coopervision-misight-1-day-officially-launches-in-china/2481026/CooperVision and EssilorLuxottica have officially launched MiSight 1 day contact lenses in China, marking its availability in the world’s largest country for myopia management. It is the first product of any type that has an indication from the Chinese National Medical Products Adminis
- Alcon Celebrates 75th Anniversaryhttps://modernod.com/news/alcon-celebrates-75-years-of-eye-care-innovation/2480862/Alcon marked the company’s 75th anniversary this week with its "Brilliant History. Brilliant Future." celebration. On May 16, 1947, Alcon Laboratories Inc. was incorporated and began manufacturing specialty pharmaceutical products in Fort Worth, Texas. To
- Schwind Celebrates 30 Years in Refractive Corneal Surgeryhttps://modernod.com/news/schwind-celebrates-30-years-in-refractive-corneal-surgery/2480804/In 2022, Schwind eye-tech-solutions is celebrating a milestone, as the company marks 30 years of driving solutions for refractive corneal surgery. During this period, Schwind has expanded its treatment options for eye surgeons and patients. Founded in 1958 and initially a successful one-stop supp